The Korean Pharmacists for Democratic Society (President: Kyung-Lim Jeon, KPDS) has pointed out the issue of antineoplastic drugs being out of stock. In the second week of April, the KPDS revealed through the ‘Stock Shortage Drugs of the Week Report’ that an estimated wholesale stock of 110 antineoplastic drugs has run out.

The 110 items with less than 5% wholesale stock remaining include ▲ Xeloda Tab 500mg (Boryung), ▲Hydrine Cap 500mg (Korea United Pharm), ▲Agrylin Cap 0.5mg (Takeda Pharmaceuticals Korea), ▲ Tasigna Cap 150mg (Novartis Korea), ▲ Alecensa Cap 150mg (Roche Korea), ▲ Kisqali Tab 200mg (Novartis Korea), ▲ Alkyloxan Tab (JW Pharmaceutical), ▲ Purinetone Tab (Korea United